Early Recognition and Management of Side Effects Related to Systemic Anticancer Therapy for Advanced Breast Cancer

dc.contributor.authorDiez de los Rios de la Serna, Celia
dc.contributor.authorBoers Doets, Christine Bettine
dc.contributor.authorWiseman, Theresa
dc.contributor.authorRadia, Bhaveet
dc.contributor.authorHammond, Ruth
dc.date.accessioned2024-07-01T09:14:18Z
dc.date.available2024-07-01T09:14:18Z
dc.date.issued2024-02-01
dc.date.updated2024-06-13T12:47:53Z
dc.description.abstractObjectives: Advances in science and technology have meant there are numerous treatment options available for people with advanced breast cancer (ABC). However, each therapeutic approach can cause side effects or adverse events, which can significantly affect the person's quality of life, overall well-being, and, in some instances, safety. This report presents an overview of the common side effects of systemic anticancer therapy and ways to manage them. Data Sources: Data sources include peer-reviewed articles sourced in electronic databases and national and international best practice guidelines (ESMO, ASCO, and MASCC guidelines). Conclusion: Systemic anticancer therapies have side effects that healthcare professionals need to know about to monitor and manage them in early stages. Nurses play an important role in patient education, early identification, monitoring, and management of treatment side effects. Implications for Nursing Practice: People with ABC face many challenges during their treatment journey. Oncology nurses, specialist nurses, and nurse practitioners can be of support by providing preventive measures and side effects management at an early stage. Nurses need to have a good understanding of toxicity management but also advanced tumor-specific cancer knowledge of the different subtypes of ABC and holistic assessment skills. They are also key to providing support and enhancing self-management and early recognition of side effects. (c) 2023 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
dc.format.extent8 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn1878-3449
dc.identifier.pmid38171975
dc.identifier.urihttps://hdl.handle.net/2445/214029
dc.language.isoeng
dc.publisherElsevier BV
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.soncn.2023.151553
dc.relation.ispartofSeminars in Oncology Nursing, 2024, vol. 40, num. 1
dc.relation.urihttps://doi.org/10.1016/j.soncn.2023.151553
dc.rightscc by-nc-nd (c) Diez de los Rios de la Serna, Celia et al, 2024
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationCàncer de mama
dc.subject.classificationDiagnòstic d'infermeria
dc.subject.otherBreast cancer
dc.subject.otherNursing diagnosis
dc.titleEarly Recognition and Management of Side Effects Related to Systemic Anticancer Therapy for Advanced Breast Cancer
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
1-s2.0-S0749208123002280-main.pdf
Mida:
2.56 MB
Format:
Adobe Portable Document Format